FI3220937T3 - Pneumolysiinimutantteja ja menetelmiä niiden käyttämiseksi - Google Patents
Pneumolysiinimutantteja ja menetelmiä niiden käyttämiseksi Download PDFInfo
- Publication number
- FI3220937T3 FI3220937T3 FIEP15861711.8T FI15861711T FI3220937T3 FI 3220937 T3 FI3220937 T3 FI 3220937T3 FI 15861711 T FI15861711 T FI 15861711T FI 3220937 T3 FI3220937 T3 FI 3220937T3
- Authority
- FI
- Finland
- Prior art keywords
- methods
- acid sequence
- pneumolysin
- purified mutant
- vaccine
- Prior art date
Links
- 101710183389 Pneumolysin Proteins 0.000 title claims 4
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462082848P | 2014-11-21 | 2014-11-21 | |
| PCT/US2015/061859 WO2016081839A1 (en) | 2014-11-21 | 2015-11-20 | Pneumolysin mutants and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3220937T3 true FI3220937T3 (fi) | 2024-11-29 |
Family
ID=56014598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP15861711.8T FI3220937T3 (fi) | 2014-11-21 | 2015-11-20 | Pneumolysiinimutantteja ja menetelmiä niiden käyttämiseksi |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10562941B2 (enExample) |
| EP (2) | EP4501949A3 (enExample) |
| JP (1) | JP6734274B2 (enExample) |
| KR (1) | KR102304828B1 (enExample) |
| CN (1) | CN107106635B (enExample) |
| AU (1) | AU2015349787B2 (enExample) |
| CA (1) | CA2968398A1 (enExample) |
| DK (1) | DK3220937T3 (enExample) |
| ES (1) | ES2993430T3 (enExample) |
| FI (1) | FI3220937T3 (enExample) |
| HR (1) | HRP20241627T1 (enExample) |
| HU (1) | HUE069200T2 (enExample) |
| LT (1) | LT3220937T (enExample) |
| MX (1) | MX381872B (enExample) |
| PL (1) | PL3220937T3 (enExample) |
| PT (1) | PT3220937T (enExample) |
| RS (1) | RS66221B1 (enExample) |
| SI (1) | SI3220937T1 (enExample) |
| SM (1) | SMT202400482T1 (enExample) |
| WO (1) | WO2016081839A1 (enExample) |
| ZA (1) | ZA201703881B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012134975A1 (en) | 2011-03-28 | 2012-10-04 | St. Jude Children's Research Hospital | Methods and compositions employing immunogenic fusion proteins |
| WO2018124959A2 (en) | 2016-12-28 | 2018-07-05 | Henriques Normark Birgitta | Microparticles from streptococcus pneumoniae as vaccine antigens |
| CN110967482B (zh) * | 2018-09-30 | 2023-04-07 | 重庆市畜牧科学院 | 一种山羊化脓隐秘杆菌感染检测试剂盒及其检测方法 |
| CN113264999B (zh) * | 2021-04-29 | 2023-02-28 | 星济生物(苏州)有限公司 | 中和肺炎链球菌溶血素蛋白的抗原结合蛋白及其用途 |
| WO2023039223A1 (en) * | 2021-09-09 | 2023-03-16 | Affinivax, Inc. | Multivalent pneumococcal vaccines |
| JP2024541094A (ja) | 2021-11-18 | 2024-11-06 | マトリバックス，インコーポレイティド | 免疫原性融合タンパク質組成物及びその使用の方法 |
| CN115927420A (zh) * | 2022-05-27 | 2023-04-07 | 贵州省畜牧兽医研究所 | 一种溶血素重组表达及间接elisa检测方法及应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4686102A (en) | 1984-04-12 | 1987-08-11 | American Cyanamid Company | Multivalent pneumococcal vaccine and preparation thereof |
| US6716432B1 (en) | 1988-12-16 | 2004-04-06 | James Cleland Paton | Pneumolysin mutants and pneumococcal vaccines made therefrom |
| CA2005704C (en) | 1988-12-16 | 2003-02-11 | James C. Paton | Pneumolysin mutants and pneumococcal vaccines made therefrom |
| US5854416A (en) | 1991-11-14 | 1998-12-29 | The United States Of America As Represented By The Department Of Health And Human Services | Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor |
| US5565204A (en) | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| WO1996040930A1 (en) | 1995-06-07 | 1996-12-19 | Regents Of The University Of Minnesota | Mutants of streptococcal toxin a and methods of use |
| US6764686B2 (en) | 1997-07-21 | 2004-07-20 | Baxter International Inc. | Modified immunogenic pneumolysin compositions as vaccines |
| US6224880B1 (en) | 1997-09-24 | 2001-05-01 | Merck & Co., Inc. | Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines |
| US6903184B1 (en) | 1998-03-02 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| PL204863B1 (pl) | 1998-07-22 | 2010-02-26 | Stichting Dienst Landbouwkundi | Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji |
| DK1140157T3 (da) | 1998-12-21 | 2009-06-08 | Medimmune Inc | Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner |
| US6887480B1 (en) | 1999-06-10 | 2005-05-03 | Medimmune, Inc. | Streptococcus pneumoniae proteins and vaccines |
| WO2003054007A2 (en) | 2001-12-20 | 2003-07-03 | Shire Biochem Inc. | Streptococcus antigens |
| US7217791B2 (en) | 2002-11-07 | 2007-05-15 | Synergy America, Inc. | Compositions and methods for treating or preventing pneumococcal infection |
| US20060257421A1 (en) | 2004-02-13 | 2006-11-16 | Martina Ochs | Pneumolysin derivatives |
| WO2005108419A1 (en) | 2004-05-07 | 2005-11-17 | Lea-Ann Kirkham | Mutant cholesterol-binding cytolysin proteins |
| GB0410220D0 (en) * | 2004-05-07 | 2004-06-09 | Kirkham Lea Ann | Mutant pneumolysin proteins |
| US9370557B2 (en) | 2006-06-15 | 2016-06-21 | The University Court Of The University Of Glasgow | Adjuvant compounds |
| BRPI0810211A2 (pt) * | 2007-04-13 | 2014-10-21 | Univ Oklahoma | Citolisina dependente de colesterol mutante purficada, composição, vacina, método para vacinar um paciente, anticorpo monoclonal, ácido nucléico, e, célula hospedeira. |
| CN106008679A (zh) | 2008-12-24 | 2016-10-12 | 荷兰王国卫生福利和运动部国家公共卫生和环境研究所 | 修饰的肺炎链球菌溶血素(ply)多肽 |
| CN102939105B (zh) * | 2009-12-22 | 2016-11-16 | 赛诺菲巴斯德有限公司 | 免疫原性组合物和相关的方法 |
| CL2010001216A1 (es) * | 2010-11-08 | 2011-01-28 | New Tech Copper S P A | Sistema para confinar el espacio sobre el electrolito en una celda de electro obtencion y evacuar los aerosoles generados, que comprende un confinador insertado en cada anodo, con un par de proyecciones flexibles y un par de perfiles en angulo, y ductos longitudinales con perforaciones sobre el nivel del electrolito. |
| WO2012134975A1 (en) | 2011-03-28 | 2012-10-04 | St. Jude Children's Research Hospital | Methods and compositions employing immunogenic fusion proteins |
| JP6397805B2 (ja) | 2015-08-28 | 2018-09-26 | 東芝メモリ株式会社 | 半導体製造装置およびその運転方法 |
-
2015
- 2015-11-20 JP JP2017527259A patent/JP6734274B2/ja active Active
- 2015-11-20 SI SI201532045T patent/SI3220937T1/sl unknown
- 2015-11-20 CN CN201580071394.2A patent/CN107106635B/zh active Active
- 2015-11-20 KR KR1020177016881A patent/KR102304828B1/ko active Active
- 2015-11-20 ES ES15861711T patent/ES2993430T3/es active Active
- 2015-11-20 DK DK15861711.8T patent/DK3220937T3/da active
- 2015-11-20 PT PT158617118T patent/PT3220937T/pt unknown
- 2015-11-20 HR HRP20241627TT patent/HRP20241627T1/hr unknown
- 2015-11-20 FI FIEP15861711.8T patent/FI3220937T3/fi active
- 2015-11-20 AU AU2015349787A patent/AU2015349787B2/en active Active
- 2015-11-20 US US15/527,919 patent/US10562941B2/en active Active
- 2015-11-20 MX MX2017006625A patent/MX381872B/es unknown
- 2015-11-20 RS RS20241316A patent/RS66221B1/sr unknown
- 2015-11-20 EP EP24198287.5A patent/EP4501949A3/en active Pending
- 2015-11-20 HU HUE15861711A patent/HUE069200T2/hu unknown
- 2015-11-20 PL PL15861711.8T patent/PL3220937T3/pl unknown
- 2015-11-20 CA CA2968398A patent/CA2968398A1/en active Pending
- 2015-11-20 SM SM20240482T patent/SMT202400482T1/it unknown
- 2015-11-20 WO PCT/US2015/061859 patent/WO2016081839A1/en not_active Ceased
- 2015-11-20 EP EP15861711.8A patent/EP3220937B1/en active Active
- 2015-11-20 LT LTEPPCT/US2015/061859T patent/LT3220937T/lt unknown
-
2017
- 2017-06-06 ZA ZA2017/03881A patent/ZA201703881B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170083635A (ko) | 2017-07-18 |
| AU2015349787B2 (en) | 2021-07-29 |
| DK3220937T3 (da) | 2024-12-02 |
| MX381872B (es) | 2025-03-13 |
| AU2015349787A1 (en) | 2017-06-22 |
| JP6734274B2 (ja) | 2020-08-05 |
| EP3220937B1 (en) | 2024-09-04 |
| ES2993430T3 (en) | 2024-12-30 |
| EP3220937A1 (en) | 2017-09-27 |
| LT3220937T (lt) | 2024-12-27 |
| PL3220937T3 (pl) | 2025-01-27 |
| US20180312552A1 (en) | 2018-11-01 |
| HUE069200T2 (hu) | 2025-02-28 |
| JP2017536124A (ja) | 2017-12-07 |
| EP4501949A3 (en) | 2025-04-30 |
| EP3220937A4 (en) | 2018-05-30 |
| WO2016081839A1 (en) | 2016-05-26 |
| MX2017006625A (es) | 2018-01-15 |
| ZA201703881B (en) | 2021-10-27 |
| RS66221B1 (sr) | 2024-12-31 |
| KR102304828B1 (ko) | 2021-09-27 |
| HRP20241627T1 (hr) | 2025-02-14 |
| EP4501949A2 (en) | 2025-02-05 |
| SMT202400482T1 (it) | 2025-01-14 |
| CN107106635B (zh) | 2021-10-08 |
| US10562941B2 (en) | 2020-02-18 |
| CN107106635A (zh) | 2017-08-29 |
| SI3220937T1 (sl) | 2025-03-31 |
| BR112017010696A2 (pt) | 2017-12-26 |
| PT3220937T (pt) | 2024-11-18 |
| CA2968398A1 (en) | 2016-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3220937T3 (fi) | Pneumolysiinimutantteja ja menetelmiä niiden käyttämiseksi | |
| CO2018005229A2 (es) | Vacuna de virus sincitial respiratorio | |
| IL276210B2 (en) | Mers-cov vaccine | |
| WO2018089851A3 (en) | Influenza vaccine | |
| IL236650B (en) | Immunogenic combination, nucleic acids or vectors encoding it, host cells or compositions comprising them, and therapeutic uses thereof, process of producing an infectious virus and method for recombinant production of the mycobacterial antigens | |
| MX377804B (es) | Composiciones utiles en el tratamiento de deficiencia de la ornitina transcarbamilasa (otc). | |
| JP2015214545A5 (enExample) | ||
| WO2015142671A3 (en) | Influenza virus vectors and uses therefor | |
| MX2013014109A (es) | Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria. | |
| WO2012177924A3 (en) | Influenza virus mutants and uses therefor | |
| MX2013010620A (es) | Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo. | |
| MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
| FI3564378T3 (fi) | Immunogeeninen koostumus | |
| AU2014232363A8 (en) | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom | |
| WO2014009586A3 (es) | Vectores para la transformacion de mycoplasma hyopneumoniae, cepas transformadas de m. hyopneumoniae, y uso correspondiente | |
| MD20120127A2 (en) | Recombinant Koi herpesvirus (KHV), method for its production and vaccine for the prevention of a disease caused by KHV | |
| WO2015107363A3 (en) | Mycobacterial antigen composition | |
| HK1211980A1 (en) | Multifunctional oral vaccine based on chromosome recombineering | |
| GB201017519D0 (en) | Vaccines | |
| WO2016168214A3 (en) | Immunogenic fusion proteins for the treatment of cancer | |
| MX2022003590A (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9. | |
| PH12017501795B1 (en) | Pestivirus vaccines for congenital tremors | |
| PH12018501532A1 (en) | Cancer vaccines | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| WO2015070207A3 (en) | Ama-1 epitopes, antibodies, compositions, and methods of making and using the same |